• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effect of oral potassium on urinary kallikrein excretion in essential hypertension.

作者信息

Murakami E, Hiwada K, Kokubu T, Imamura Y

机构信息

2nd Department of Internal Medicine, Ehime University School of Medicine, Japan.

出版信息

Adv Exp Med Biol. 1989;247B:133-7. doi: 10.1007/978-1-4615-9546-5_22.

DOI:10.1007/978-1-4615-9546-5_22
PMID:2610052
Abstract

Urinary kallikrein and potassium were excreted in parallel in not only static but also dynamic sodium states. Oral potassium load stimulated the release of urinary kallikrein in normotensive subjects and WHO stage I essential hypertensive patients. Stage II essential hypertensive patients had the lowest value of basal level of urinary kallikrein and showed no increase in urinary kallikrein by oral potassium load. These results suggest that the functional activity of renal kallikrein-kinin system decreases with the development of essential hypertension.

摘要

相似文献

1
Effect of oral potassium on urinary kallikrein excretion in essential hypertension.
Adv Exp Med Biol. 1989;247B:133-7. doi: 10.1007/978-1-4615-9546-5_22.
2
Urinary kallikrein in normotensive subjects and in patients with essential hypertension.正常血压受试者和原发性高血压患者的尿激肽释放酶
Clin Exp Hypertens (1978). 1980;2(3-4):693-708. doi: 10.3109/10641968009037137.
3
Effect of furosemide on urinary kallikrein excretion in patients with essential hypertension.速尿对原发性高血压患者尿激肽释放酶排泄的影响。
Tohoku J Exp Med. 1978 Mar;124(3):197-203. doi: 10.1620/tjem.124.197.
4
Urinary kallikrein in normotensive subjects and in patients with essential hypertension.正常血压受试者和原发性高血压患者的尿激肽释放酶
Clin Sci (Lond). 1979 Dec;57 Suppl 5:247s-250s. doi: 10.1042/cs057247s.
5
Effects of dietary potassium and race on urinary excretion of kallikrein and aldosterone in man.饮食钾和种族对人体尿激肽释放酶及醛固酮排泄的影响。
J Clin Endocrinol Metab. 1978 Aug;47(2):296-9. doi: 10.1210/jcem-47-2-296.
6
[The effect of dopaminergic stimulation and inhibition on the urinary excretion of aldosterone and kallikrein in spontaneously hypertensive rats].[多巴胺能刺激与抑制对自发性高血压大鼠醛固酮和激肽释放酶尿排泄的影响]
Boll Soc Ital Biol Sper. 1983 Oct 30;59(10):1435-41.
7
The effect of sodium and potassium loading on urinary kallikrein-like activity in young patients with borderline hypertension.钠和钾负荷对临界高血压年轻患者尿激肽释放酶样活性的影响。
Jpn Circ J. 1985 Nov;49(11):1151-8. doi: 10.1253/jcj.49.1151.
8
[Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].[高血压患者后代中激肽释放酶-激肽系统和肾素-血管紧张素-醛固酮系统的选定成分]
Ann Acad Med Stetin. 1996;42:123-38.
9
Urinary kallikrein activity is not altered in human essential hypertension.
Uremia Invest. 1985;9(2):189-93. doi: 10.3109/08860228509088210.
10
Increased urinary kallikrein excretion in young borderline hypertensive patients.
Clin Exp Hypertens A. 1983;5(6):903-18. doi: 10.3109/10641968309081816.

引用本文的文献

1
Gut sensing of potassium intake and its role in potassium homeostasis.肠道感知钾摄入及其在钾稳态中的作用。
Semin Nephrol. 2013 May;33(3):248-56. doi: 10.1016/j.semnephrol.2013.04.005.
2
Tissue kallikrein permits early renal adaptation to potassium load.组织激肽释放酶可使肾脏早期适应钾负荷。
Proc Natl Acad Sci U S A. 2010 Jul 27;107(30):13526-31. doi: 10.1073/pnas.0913070107. Epub 2010 Jul 12.
3
Early increases in renal kallikrein secretion on administration of potassium or ATP-sensitive potassium channel blockers in rats.
给予大鼠钾或ATP敏感性钾通道阻滞剂后肾激肽释放酶分泌的早期增加。
Br J Pharmacol. 1999 Nov;128(6):1275-83. doi: 10.1038/sj.bjp.0702899.